Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06212453 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction

Study acronym: BETTANY
StatusTerminated
PhasePhase 2
Started2024-04-24
View on ClinicalTrials.gov ↗

Amendment history

2026-10-02
Trial terminated: Due to a lack of recruitment
Final enrollment: 8 participants (planned 22)
Primary completion confirmed: July 2025 (last estimated April 2025)
2025-01-17
Not Yet Recruiting→Recruiting Study Identification, Study Status, Oversight, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-04→confirmed 2024-04-24
Study sitesdetails revised at 1 of 1 site
Study titlerevised
[...] ermal Ablation of the Prostate Transition Zone, in Patients Withwith Benign Prostatic Hyperplasia-related Obstruction
2024-03-25
Study Status, Outcome Measures v2
Primary completion date2025-03→2025-04
Completion date2026-07→2026-08
Start date2024-03→2024-04
Secondary endpoints12 to 11 entries
Danish Prostatic Symptom Score (DAN PSS-Sex)
2024-01-23
Study Status, Arms and Interventions v1
Study arms0→1
2024-01-08
Original filing
The aim of the current study is to evaluate the efficacy of transperineal focal microwave ablation (TMA) of the prostate transition zone as a new treatment for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) within a prospective single-institutional pilot study.
Trial Details
NCT Number NCT06212453
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions Benign Prostatic Hyperplasia
Enrollment 8 participants
Start Date 2024-04-24
Primary Completion 2025-07-15 (estimated)
Study Completion 2025-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-10-01